EA201791850A1 - Борсодержащие малые молекулы - Google Patents

Борсодержащие малые молекулы

Info

Publication number
EA201791850A1
EA201791850A1 EA201791850A EA201791850A EA201791850A1 EA 201791850 A1 EA201791850 A1 EA 201791850A1 EA 201791850 A EA201791850 A EA 201791850A EA 201791850 A EA201791850 A EA 201791850A EA 201791850 A1 EA201791850 A1 EA 201791850A1
Authority
EA
Eurasian Patent Office
Prior art keywords
boron
small molecules
containing small
compounds
treating
Prior art date
Application number
EA201791850A
Other languages
English (en)
Other versions
EA033311B1 (ru
Inventor
Винсент С. Эрнандес
Чарльз Дин
Джейкоб Дж. Плэттнер
Майкл Ричард Кевин Элли
Фернандо Рок
Суоминг Чжанг
Эрик Исом
Сяньфэн Ли
Дин Чжоу
Original Assignee
Анакор Фармасьютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анакор Фармасьютикалс, Инк. filed Critical Анакор Фармасьютикалс, Инк.
Publication of EA201791850A1 publication Critical patent/EA201791850A1/ru
Publication of EA033311B1 publication Critical patent/EA033311B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к соединениям, имеющим структуру (I), к композиции, комбинации и фармацевтическому составу, содержащим указанные соединения, к способу in vitro с использованием указанных соединений, а также к их применению для лечения и/или предотвращения бактериальных инфекций.
EA201791850A 2010-09-07 2011-09-07 Производные бензоксаборола в качестве антибактериальных средств EA033311B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38059610P 2010-09-07 2010-09-07

Publications (2)

Publication Number Publication Date
EA201791850A1 true EA201791850A1 (ru) 2018-01-31
EA033311B1 EA033311B1 (ru) 2019-09-30

Family

ID=44653589

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201791850A EA033311B1 (ru) 2010-09-07 2011-09-07 Производные бензоксаборола в качестве антибактериальных средств
EA201390274A EA028743B1 (ru) 2010-09-07 2011-09-07 Производные бензоксаборолов в качестве антибактериальных средств

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201390274A EA028743B1 (ru) 2010-09-07 2011-09-07 Производные бензоксаборолов в качестве антибактериальных средств

Country Status (25)

Country Link
US (4) US8703742B2 (ru)
EP (2) EP2613788B1 (ru)
JP (4) JP5952280B2 (ru)
KR (2) KR101949423B1 (ru)
CN (2) CN103140228A (ru)
AU (1) AU2011299243C1 (ru)
BR (1) BR112013005426B1 (ru)
CA (1) CA2810021C (ru)
CY (1) CY1124728T1 (ru)
DK (2) DK2613788T3 (ru)
EA (2) EA033311B1 (ru)
ES (2) ES2635333T3 (ru)
HK (1) HK1247841A1 (ru)
HR (1) HRP20211762T1 (ru)
HU (1) HUE059033T2 (ru)
IL (2) IL225000A (ru)
LT (1) LT3251678T (ru)
MX (1) MX338209B (ru)
PL (1) PL3251678T3 (ru)
PT (1) PT3251678T (ru)
RS (1) RS62548B1 (ru)
SG (2) SG10201507032YA (ru)
SI (1) SI3251678T1 (ru)
WO (1) WO2012033858A2 (ru)
ZA (1) ZA201301598B (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1976536A4 (en) 2005-12-30 2011-03-02 Anacor Pharmaceuticals Inc SMALL MOLECULES CONTAINING BORON
US9440994B2 (en) 2009-08-14 2016-09-13 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
CA2810021C (en) * 2010-09-07 2018-05-29 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2793901A1 (en) 2011-12-22 2014-10-29 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
NZ710723A (en) 2013-01-30 2019-12-20 Agrofresh Inc Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US9598443B2 (en) 2013-02-01 2017-03-21 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
AU2014305792C1 (en) * 2013-08-09 2018-07-05 Anacor Pharmaceuticals, LLC. Tricyclic benzoxaborole compounds and uses thereof
EA038093B1 (ru) * 2013-12-20 2021-07-05 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
CA2953881A1 (en) * 2014-07-01 2016-01-07 Daiichi Sankyo Company, Limited Tricyclic benzoxaboroles as antibacterial agents
MA41495A (fr) * 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations
RS64770B1 (sr) 2016-03-07 2023-11-30 Agrofresh Inc Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
CN111655035A (zh) 2017-11-30 2020-09-11 博瑞金股份有限公司 苯并氧杂硼杂环戊烯化合物和其制剂
CN108727176B (zh) * 2018-07-26 2021-05-18 荆楚理工学院 一种制备5-卤-2,3-二羟基苯甲醛的方法
AU2019325436B2 (en) 2018-08-18 2023-10-26 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
US20220275007A1 (en) * 2019-07-30 2022-09-01 Boragen, Inc. Flow reaction process for manufacture of boron-containing agrochemicals
CN110664756B (zh) * 2019-10-09 2020-11-17 吉林大学 一种小儿外伤喷雾剂及其制备方法
WO2022043936A1 (en) 2020-08-31 2022-03-03 Pfizer Inc. Methods of protecting rna
WO2023246842A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
WO2023246841A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
CN115572218B (zh) * 2022-08-29 2024-04-16 江阴勒森生物科技有限公司 一种2-溴-3-羟基苯甲醛及其相关化学发光底物中间体的制备方法

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260336A (en) 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
US3686398A (en) 1970-07-20 1972-08-22 Chevron Res 10,9-boroxarophenanthrene as fungicides
GB1396904A (en) 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US4766113A (en) 1975-10-24 1988-08-23 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4602011A (en) 1975-10-24 1986-07-22 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5962498A (en) 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5274792A (en) 1989-08-19 1993-12-28 Fujitsu Limited Information processing apparatus with parallel instruction decoding
SG47101A1 (en) 1992-07-31 1998-03-20 Us Bioscience Crystalline amifostine compositions and methods for the preparation and use of same
US5348948A (en) 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en) 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5594151A (en) 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en) 1995-01-17 1995-03-08 Zeneca Ltd Composition and use
GB9604926D0 (en) 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
CA2258728C (en) 1996-06-19 2011-09-27 Rhone Poulenc Rorer Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en) 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
US6413751B1 (en) 1996-09-19 2002-07-02 The Board Of Trustees Of The Leland Stanford Jr. University DNA adenine methyltransferases and uses thereof
AU4967997A (en) 1996-12-02 1998-06-29 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US6221640B1 (en) 1997-05-14 2001-04-24 Cubist Pharmaceuticals, Inc. Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
DE19829947A1 (de) 1998-07-04 2000-01-05 Bayer Ag Elektrolumineszierende Anordnungen mit Bor-Chelaten
US6462036B1 (en) 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
JP2003517447A (ja) 1998-11-06 2003-05-27 ビーエーエスエフ アクチェンゲゼルシャフト 三環式ピラゾール誘導体
WO2000044387A1 (fr) 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
JP2003501431A (ja) 1999-05-25 2003-01-14 ザ ペン ステート リサーチ ファウンデイション Ｄｎａメチル基転移酵素阻害剤
DE60045879D1 (de) 1999-08-25 2011-06-01 Ambergen Inc Methoden zur Detektion, Analyse und Isolation von entstehenden Proteinen
US6306628B1 (en) 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
WO2001025226A1 (en) 1999-10-05 2001-04-12 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
AU784593B2 (en) 2000-01-06 2006-05-11 Marantech Holding, Llc Compositions and methods for facilitating skin growth and managing skin conditions
US6521619B2 (en) 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
EP1303625A2 (en) 2000-07-14 2003-04-23 Zycos Inc. Alpha-msh related compounds and methods of use
DE60124759T2 (de) 2000-11-30 2007-03-15 The Penn State Research Foundation Dna methyl transferase inhibitoren
DE10110051C2 (de) 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
US7217701B2 (en) 2001-10-11 2007-05-15 Katsuhiko Mikoshiba Intracellular calcium concentration increase inhibitors
JP4138662B2 (ja) 2002-01-10 2008-08-27 ザ・ペンシルバニア・ステイト・リサーチ・フアウンデイシヨン アルキルジアリールボリネートおよび錯化ジアリールボロン酸を調製するための方法。
AU2003248921A1 (en) 2002-07-09 2004-01-23 Point Therapeutics, Inc. Boroproline compound combination therapy
ES2283867T3 (es) 2002-12-02 2007-11-01 Solvias Ag Hidrogenacion catalitica de dobles enlaces de carbonoheteroatomo.
CA2509645A1 (en) 2002-12-18 2004-07-08 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
US7390806B2 (en) 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
US20050125852A1 (en) 2003-05-09 2005-06-09 Sugen, Inc. Novel kinases
AU2004262524C1 (en) 2003-06-16 2010-08-19 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
DK1755661T3 (da) 2004-05-12 2014-06-16 Brigham & Womens Hospital Gelsolin til anvendelse til behandling af infektioner
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
WO2006062731A1 (en) 2004-11-19 2006-06-15 University Of North Texas Health Science Center At Fort Worth Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en) 2005-01-31 2005-03-09 Univ Cambridge Tech Compounds for use in chemical detection and/or quantitation
SI3424932T1 (sl) * 2005-02-16 2021-08-31 Anacor Pharmaceuticals, Inc. Boronoftalidi za terapevtsko uporabo
EP1856113B1 (en) 2005-03-08 2016-01-06 Agency for Science, Technology and Research Chiral bisoxazoline catalysts
TW200722087A (en) 2005-03-30 2007-06-16 Astion Dev As Treatment of dermatological diseases and pruritus
WO2007022437A2 (en) 2005-08-18 2007-02-22 Auspex Pharmaceuticals, Inc. Therapeutic agents for the treatment of cancer and metabolic disorders
EP1976536A4 (en) 2005-12-30 2011-03-02 Anacor Pharmaceuticals Inc SMALL MOLECULES CONTAINING BORON
PL1988779T3 (pl) 2006-02-16 2015-10-30 Anacor Pharmaceuticals Inc Małe cząsteczki zawierające bor jako środki przeciwzapalne
WO2007131072A2 (en) * 2006-05-02 2007-11-15 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
RU2008152367A (ru) 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
US20070286822A1 (en) 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2009111676A2 (en) 2008-03-06 2009-09-11 Anacor Pharmaceuticals, Inc Boron-containing small molecules as anti-inflammatory agents
EP3246034A1 (en) 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
WO2009140309A2 (en) 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010045505A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Boron-containing small molecules as anti-protozoal agents
WO2010045503A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
CA2744231A1 (en) 2008-12-17 2010-07-15 Anacor Pharmaceuticals, Inc. Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
US8343944B2 (en) 2009-07-28 2013-01-01 Anacor Pharmaceuticals, Inc. Trisubstituted boron-containing molecules
CA2810021C (en) * 2010-09-07 2018-05-29 Anacor Pharmaceuticals, Inc. Boron-containing small molecules

Also Published As

Publication number Publication date
US8703742B2 (en) 2014-04-22
PL3251678T3 (pl) 2022-01-10
AU2011299243C1 (en) 2016-06-02
KR101949423B1 (ko) 2019-02-18
US20140315860A1 (en) 2014-10-23
CN108610356B (zh) 2021-02-26
DK3251678T3 (da) 2021-11-22
JP5952280B2 (ja) 2016-07-13
ES2898695T3 (es) 2022-03-08
IL225000A (en) 2016-03-31
EP3251678A1 (en) 2017-12-06
EA033311B1 (ru) 2019-09-30
EP2613788B1 (en) 2017-06-21
ZA201301598B (en) 2021-08-25
EP2613788A2 (en) 2013-07-17
JP6491294B2 (ja) 2019-03-27
CN103140228A (zh) 2013-06-05
HUE059033T2 (hu) 2022-10-28
LT3251678T (lt) 2021-12-10
US20190345173A1 (en) 2019-11-14
CN108610356A (zh) 2018-10-02
US20170355719A1 (en) 2017-12-14
JP2019112431A (ja) 2019-07-11
BR112013005426A2 (pt) 2016-06-07
JP2013541514A (ja) 2013-11-14
CA2810021C (en) 2018-05-29
JP2016199558A (ja) 2016-12-01
CY1124728T1 (el) 2022-07-22
WO2012033858A3 (en) 2012-05-10
IL244556A0 (en) 2016-04-21
SG187969A1 (en) 2013-04-30
US11008345B2 (en) 2021-05-18
EP3251678B1 (en) 2021-10-20
SG10201507032YA (en) 2015-10-29
MX2013002651A (es) 2013-04-19
AU2011299243A1 (en) 2013-03-28
JP2018058836A (ja) 2018-04-12
PT3251678T (pt) 2021-11-22
US9751898B2 (en) 2017-09-05
KR102152901B1 (ko) 2020-09-07
AU2011299243B2 (en) 2015-09-17
IL244556B (en) 2020-07-30
KR20190018549A (ko) 2019-02-22
KR20140093598A (ko) 2014-07-28
HRP20211762T1 (hr) 2022-02-18
SI3251678T1 (sl) 2022-01-31
ES2635333T3 (es) 2017-10-03
WO2012033858A2 (en) 2012-03-15
ES2898695T8 (es) 2022-03-16
RS62548B1 (sr) 2021-12-31
BR112013005426B1 (pt) 2021-08-24
DK2613788T3 (en) 2017-08-07
HK1247841A1 (zh) 2018-10-05
EA028743B1 (ru) 2017-12-29
US20120115813A1 (en) 2012-05-10
CA2810021A1 (en) 2012-03-15
EA201390274A1 (ru) 2013-08-30
MX338209B (es) 2016-04-07

Similar Documents

Publication Publication Date Title
EA201791850A1 (ru) Борсодержащие малые молекулы
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
EA201170772A1 (ru) Органические соединения
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201500265A1 (ru) Ингибиторы репликации вирусов гриппа
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
EA201200951A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA201071320A1 (ru) Активаторы глюкокиназы
EA201391285A1 (ru) Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201100037A1 (ru) Органические соединения
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201290880A1 (ru) Новые соединения - ингибиторы фермента
EA201391030A1 (ru) Композиции моноциклина для местного применения и способы их применения
PH12015501609A1 (en) Phenicol antibacterials
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201400537A1 (ru) 18-МЕТИЛ-6,7-МЕТИЛЕН-3-ОКСО-17-ПРЕГН-4-ЕН-21,17β-КАРБОЛАКТОНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЭНДОМЕТРИОЗА
UA106875C2 (uk) Тіадіазолілоксифеніламідини та їх застосування як фунгіцидів
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
EA201390799A1 (ru) Триазолопиридины